Innodal receives FSIS approval for latest Listeria control processing aid

Canadian biotechnology company Innodal recently announced it was issued a No Objection Letter (NOL) from the US Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) confirming the acceptability of its product Inneo, designed to be a processing aid to control Listeria monocytogenes in red meat and poultry products.

Innodal specializes in developing natural food safety solutions based on antimicrobial compounds derived from probiotic strains.

The approval allows US meat and poultry processors to use Inneo as a surface treatment and directly within the food matrix of comminuted products.

“This No Objection Letter from USDA-FSIS is a major milestone for Inneo,” said Laurent Dallaire, chief executive officer and co-founder of Innodal. “It confirms that processors can confidently use our bacteriocin-based technology not only on product surfaces, but also directly within comminuted meat and poultry products.”

According to Innodal, FSIS confirmed it has no objection to Inneo as an antimicrobial intervention when applied on product surfaces or mixed into ready-to-eat formulations, enabling full regulatory compliance within FSIS-regulated establishments.

“Inneo is a natural antimicrobial processing aid based on a bacteriocin, a class of peptides recognized for their targeted activity against Listeria monocytogenes,” the company added. “The technology previously received GRAS status from the FDA, and this FSIS NOL now provides the final regulatory clarity required for deployment across red meat and poultry applications, including surface applications and in-product applications where Inneo is mixed directly into comminuted ready-to-eat meat and poultry.”